Document and Entity Information
Document and Entity Information | Jan. 12, 2023 |
Cover [Abstract] | |
Amendment Flag | true |
Amendment Description | This Amendment No. 1 on Form 8-K/A (“Amendment No. 1”) amends the Current Report on Form 8-K of Cyteir Therapeutics, Inc. (the “Company”) filed with the Securities and Exchange Commission on January 19, 2023. The purpose of this Amendment No. 1 is to add Item 2.02, which had been inadvertently omitted from the original filing. |
Entity Central Index Key | 0001662244 |
Document Type | 8-K/A |
Document Period End Date | Jan. 12, 2023 |
Entity Registrant Name | Cyteir Therapeutics, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-40499 |
Entity Tax Identification Number | 45-5429901 |
Entity Address, Address Line One | 128 Spring St, Building A |
Entity Address, Address Line Two | Suite 510 |
Entity Address, City or Town | Lexington |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02421 |
City Area Code | 857 |
Local Phone Number | 285-4140 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.001 par value per share |
Trading Symbol | CYT |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |